Skip to content
10-Q

Quarterly Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-21-011126

← back to feed
Filed
May 12, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · May 12, 2021 160.74M sh
Cash And Equivalents Q3 2020 · Sep 30, 2020 $54.54K
Cash And Equivalents Q3 2020 · Dec 31, 2019 $14.83K
Current Liabilities Q3 2020 · Sep 30, 2020 $3.47M
Current Liabilities Q3 2020 · Dec 31, 2019 $2.19M
Total Liabilities Q3 2020 · Sep 30, 2020 $4.19M
Total Liabilities Q3 2020 · Dec 31, 2019 $2.88M
Current Assets Q3 2020 · Sep 30, 2020 $759.56K
Current Assets Q3 2020 · Dec 31, 2019 $604.43K
Total Assets Q3 2020 · Sep 30, 2020 $4.44M
Total Assets Q3 2020 · Dec 31, 2019 $4.47M
Stock Issued Q3 2020 · Apr 30, 2020 384.62K sh
Stock Issued Q3 2020 · Mar 31, 2020 1.54M sh
Capex restated Q3 2020 · Sep 30, 2019 $1.46M
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$2.44M
Net Income Q3 2020 · Sep 30, 2019 −$927.17K
Net Income Q3 2020 · Sep 30, 2019 −$2.77M
Net Income Q3 2020 · Jun 30, 2019 −$555.6K
Net Income Q3 2020 · Mar 31, 2019 −$1.29M
Operating Income Q3 2020 · Sep 30, 2019 −$869.76K
Operating Income Q3 2020 · Sep 30, 2019 −$2.4M
Gross Profit Q3 2020 · Sep 30, 2019 $66.49K
Gross Profit Q3 2020 · Sep 30, 2019 $715.6K
Revenue Q3 2020 · Sep 30, 2019 $527.39K
Revenue Q3 2020 · Sep 30, 2019 $1.97M